Related Experiment Video
Updated: Aug 3, 2026

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
Malignant peripheral nerve sheath tumors with t(X;18). A pathologic and molecular genetic study
M J O'Sullivan1, M Kyriakos, X Zhu
1L. V. Ackerman Laboratory of Surgical Pathology, Washington University Medical Center, St. Louis, Missouri 63110, USA.
The chromosomal translocation t(X;18) is not specific to synovial sarcoma, as it was found in 75% of malignant peripheral nerve sheath tumors. This finding challenges its use as a diagnostic hallmark for synovial sarcoma.
Area of Science:
- Oncology
- Pathology
- Genetics
Background:
- Spindle cell sarcomas pose diagnostic challenges due to histological similarities.
- Immunohistochemistry and electron microscopy can aid differentiation but may be inconclusive.
- Cytogenetic and molecular genetic analyses offer advanced diagnostic tools.
Purpose of the Study:
- To evaluate the specificity of the chromosomal translocation t(X;18) for diagnosing synovial sarcoma.
- To investigate the presence of t(X;18) in other spindle cell tumors.
Main Methods:
- Reverse transcriptase-polymerase chain reaction (RT-PCR) was used to detect t(X;18).
- RNA was extracted from formalin-fixed, paraffin-embedded tissues of various soft tissue and spindle cell tumors.
- The study cohort included synovial sarcomas and malignant peripheral nerve sheath tumors.
Main Results:
- The t(X;18) translocation was detected in 85% of the studied synovial sarcomas.
- Notably, 75% of the malignant peripheral nerve sheath tumors also exhibited the t(X;18) translocation.
- This indicates a lack of specificity for synovial sarcoma diagnosis.
Conclusions:
- The chromosomal translocation t(X;18) is not a specific diagnostic marker for synovial sarcoma.
- The high prevalence of t(X;18) in malignant peripheral nerve sheath tumors has significant diagnostic implications.
- Rethinking the diagnostic criteria for these tumors is necessary.
More Related Videos
09:33Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor
Published on: August 25, 2023
08:57Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models
Published on: May 17, 2024